The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Evaluating the performance of four anti-dsDNA antibody detection methods
Abstract
Objective To evaluate the concordance of four anti-dsDNA antibody detection methods—Crithidia luciliae indirect immunofluorescence test (CLIFT), enzyme-linked immunosorbent assay (ELISA), acridine ester direct chemiluminescence immunoassay (CLIA), and digital liquid chip method (DLCM)—and to assess their diagnostic efficacy in systemic lupus erythematosus (SLE) patients. Methods A total of 285 serum samples were collected, including 170 SLE patients, 39 with non-SLE autoimmune diseases (AIDs), 28 with non-AIDs, and 48 undiagnosed cases. The concordance and diagnostic performance of anti-dsDNA antibody methods were analyzed. Results The diagnostic performance showed that DLCM exhibited the highest sensitivity (86.87%), while CLIA demonstrated the highest specificity (94.03%). The area under the receiver operating characteristic (ROC) curve (AUC) was ranked as CLIFT < ELISA < CLIA < DLCM (AUC = 0.938). Anti-dsDNA antibodies detected by both CLIFT and DLCM correlated well with the SLE disease activity index (SLEDAI), while CLIFT and CLIA were significantly correlated with lupus nephritis. Utilizing ROC curve-derived cut-off values, the overall concordance of CLIFT and other methods ranged from 80.14% to 82.58% (kappa > 0.6, P < 0.001), and the concordance between quantitative methods ranged from 89.55% to 91.29% (kappa > 0.8, P < 0.001). Conclusion CLIFT, ELISA, CLIA, and DLCM all showed impressive diagnostic efficacy in detecting anti-dsDNA antibodies. CLIFT shows a strong correlation with SLE activity and lupus nephritis. DLCM, a relatively new method, also showed excellent performance and could be integrated into clinical laboratory workflows for anti-dsDNA antibody testing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
The ASA Statement on p -Values: Context, Process, and Purpose
Wasserstein, R. L., & Lazar, N. A. (2016) · The American Statistician · doi:10.1080/00031305.2016.1154108 · Cited by 6,306
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A., & Harley, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021933 · Cited by 2,578
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Fanouriakis, A., Kostopoulou, M., Alunno, A., Aringer, M., Bajema, I., Boletis, J. N., Cervera, R., Doria, A., Gordon, C., Govoni, M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215089 · Cited by 2,011
Aringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey-Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214819 · Cited by 1,612
Tian, J., Zhang, D., Yao, X., Huang, Y., & Lu, Q. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223035 · Cited by 620
Aarden, L. A., Groot, E. R. D., & Feltkamp, T. E. W. (1975) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1975.tb29197.x · Cited by 563
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
Rovin, B. H., Ayoub, I. M., Chan, T. M., Liu, Z.-H., Mejía-Vilet, J. M., & Floege, J. (2024) · Kidney International · doi:10.1016/j.kint.2023.09.002 · Cited by 517
Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein
Holman, H. R., & Kunkel, H. G. (1957) · Science · doi:10.1126/science.126.3265.162 · Cited by 283
Research works printed but not linked: 1
- Group CLNDaTGW. Chinese guidelines for diagnosis and treatment of lupus nephritis. Zhonghua Yixue Zazhi 2019; 99: 3441–3455.
Cited by
Lu, L., Lu, L., Zhang, H., et al. (2026) · Microchemical Journal · doi:10.1016/j.microc.2026.119479
Metadata
- Authors
- Gao, X., Wu, L., Li, Y., Wang, L., Huang, Z., Zhang, J., Su, Z., & Yang, B.
- Affiliations
- Sichuan University (CN)
- Clinical Laboratory, Baoshan People’s Hospital of Yunnan Province, Baoshan, China
- Corresponding author
- Su, Zhenzhen
- Yang, Bin
- Venue
- Lupus
- Publisher
- SAGE Publications
- Published
- 2025-08-23
- Volume
- 34
- Issue
- 12
- Pages
- 1251-1260
- ISSN
- 0961-2033 (ISSN-L)
- 1477-0962
- OpenAlex
- W4413452534
- Cited by
- 1
- References
- 33
- Citations by year
- 2026: 1
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Lupus (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Natural Science Foundation of Sichuan Province (2024YFFK0222)
- National Key R&D Program of China (2022YFC2406600/2022YFC2406604)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- anti-dsDNA antibodies, systemic lupus erythematosus, chemiluminescence immunoassay, ELISA, diagnostic agreement, sensitivity and specificity, SLE disease activity, lupus nephritis, autoimmune disease diagnosis
- MeSH terms
- Adult, Animals, Antibodies, Antinuclear, Crithidia, DNA, Enzyme-Linked Immunosorbent Assay, Female, Humans, Luminescent Measurements, Lupus Erythematosus, Systemic, Lupus Nephritis, Male, Middle Aged, ROC Curve, Sensitivity and Specificity, Fluorescent Antibody Technique, Indirect, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluating the performance of four anti-dsDNA antibody detection methods. https://app.cochat.ai/papers/10.1177/09612033251371116
- The paper
- Gao, X., Wu, L., Li, Y., Wang, L., Huang, Z., Zhang, J., Su, Z., & Yang, B. (2025). Evaluating the performance of four anti-dsDNA antibody detection methods. Lupus. https://doi.org/10.1177/09612033251371116
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.